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Abstract
The purpose of this study was to evaluate the heart rate variability (HRV) level and the features of early post-infarction left 
ventricular remodeling (PIR) in patients with recurrent myocardial infarction (MI), which developed within six months post the 
initial Q-wave MI (Q-MI).
Material and Methods: The study surveyed 105 male patients between 29 and 69 years of age (mean age 52.08±8.5), 
who  underwent  a  Q-MI  and  who,  for  various  reasons,  have  not  undergone  coronary  angiography. All  patients  underwent 
echocardiography and the LVM, EDV, ESV and their indexed values, as well as the ejection fraction were determined, including 
Holter  ECG  monitoring.  In  the  interim,  analysis  included  the  indicators  recommended  by  the  standards  of  measurement, 
physiological interpretation and clinical use of heart rate variability, such as SDNN, SDANN and RMSSD. The reduction of the 
total reduction of HRV was taken as SDNN≤100ms, and the marked reduction in HRV - SDNN≤50ms. 
Results: All the patients were divided into two groups:  Group I consisted of patients who, within six months after the initial 
Q-wave MI, developed fatal or nonfatal reinfarction; Group II included those patients with a favorable course of the disease. 
The patients in both groups belonged to a somewhat similar age category. By localization of MI, occurrence of AH, as well as 
the incidence of LV aneurysm, both groups were comparable. However, the Group I patients in acute Q-MI showed significantly 
more preserved signs of residual myocardial ischemia, which was manifested as early post-infarction angina. The average values     
of SDNN in patients in Group I were noted to be significantly lower than that in the Group II patients. The same ratio was 
observed in both groups and also the indicator of SDANN, whereas the mean     RMSSD values of the patients of both groups were 
not significantly different. The percentage of patients with reduced HRV in Group I was 1.8 times higher than that in Group II, 
including those patients with a marked reduction in HRV, which were 25% and 5.1% in Groups I and II, respectively. The patients 
in Group I compared with Group II patients had significantly higher values     for LVM, EDV, ESV, as well as their indexed values 
for     LVMI, iEDV, and iESV. The average values     of EF in Group I were significantly lower than those in Group II.
Conclusion: In patients with recurrent MI, which had developed within six months from the time of the initial Q-infarction 
in the acute phase of the disease, significantly more preserved signs of residual ischemia were revealed. The average EF, SDNN 
and SDANN values     in these patients were significantly lower than in patients having a favorable course of the disease. Patients 
with recurrent MI differed significantly by showing higher values     of the left ventricular mass, left ventricular volume indices, as 
well as the indexed values     determined during the 10-14 day period of the primary IM.
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Introduction
The course of the disease in patients with myocardial 
infarction (MI) varies in each individual case. MI can occur 
without or with complications, which do not worsen the long-
term prognosis. At the same time, about half of the patients in 
the acute and subacute periods have complications leading to 
deterioration of the disease and even death. Anticipating the 
development of such complications is not always possible even 
by  experienced  specialists. Thus,  one  of  the  complications 
of myocardial infarction is the development of reinfarction, 
including fatal reinfarction. In light of this fact, predicting the 
complications caused by MI in order to be able to promptly 
perform the necessary preventive measures appears to be an 
urgent need. 
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As well recognized, the post-MI decline of heart rate 
variability (HRV) reliably indicates imminently threatening 
ventricular  tachyarrhythmias  (paroxysmal  ventricular 
tachycardia,  ventricular  fibrillation)  and  sudden  death. 
However, HRV is not dependent on the decreased left ventricle 
ejection  fraction  (LVEF),  increased  ventricular  ectopic 
activity or the presence of late potentials; it is an independent 
predictor of the risk of death in patients with acute myocardial 
infarction.  Nevertheless,  the  combination  of  reduced  HRV 
with one of the parameters mentioned above, especially with 
the  reduced  left  ventricular  ejection  fraction,  facilitates  a 
reliable prediction.
The  complex  set  of  changes  occurring  in  the  heart 
post  acute  MI,  as  described  by  Pfeffer  M.  and  Braunwald 
E.,  involves  “post-infarction  left  ventricular  remodeling” 
(PIR)  [1-3].  Remodeling  is  a  process  of  adaptation  of  the 
left ventricle (LV) in an attempt to maintain its contractile 
function  by  expanding  the  heart  chambers  and  myocardial 
hypertrophy. However, the progression of this process leads 
to  the  breakdown  of  the  compensatory  mechanisms  and 
the  remodeling  of  the  LV  acquires  maladjustment  features 
revealing the phenomena of increasing dilation, changing the 
geometry of the LV, eccentric myocardial hypertrophy and 
thereby the development of chronic heart failure. Patients with 
severe PIR are at high risk for cardiovascular events, including 
sudden death due to arrhythmias.
The purpose of this study was to evaluate the HRV level 
and the features of early PIR in patients with recurrent MI, 
which developed within six months post the initial Q-wave 
MI (Q-MI).
Material and Methods
The study surveyed 105 male patients between 29 and 
69 years of age (mean age 52.08±8.5), who underwent a Q-MI 
and who, for various reasons, have not undergone coronary 
angiography. The diagnosis of acute MI was established based 
on the complaints, history, electrocardiographic data, as well 
as laboratory studies in accordance with the WHO-prescribed 
criteria (1978).
The exclusion criteria included the presence of violations 
of  the  sinuauricular  or  atrioventricular  conduction,  lack  of 
sustained  sinus  rhythm  (supravetricular  tachyarrhythmia, 
nodal rhythm, frequent premature beats - with allodromy or 
number of extrasystoles exceeding 20%     of total ventricular 
complexes), previous MI, non-Q MI, hyperthermia, as well 
as the presence of diseases that induce significant changes 
in  the  HRV,  such  as  diabetes  mellitus,  hypothyroidism  or 
hyperthyroidism,  alcoholism,  severe  respiratory,  kidney  or 
liver failure, cancer, etc.
The  initial  evaluation  of  the  study  protocol  was 
conducted  10-14  days  post  infarction  due  to  the  standard 
therapy, including the agents (antiplatelets, β-blockers, ACE 
inhibitors  or ARA  II,  statins  and,  if  necessary,  nitrates)  in 
adjusted doses. All patients underwent echocardiography and 
the left ventricular mass (LVM), end-diastolic volume  (EDV), 
end-systolic volume  (ESV) and their indexed values, as well 
as the ejection fraction  (EF) were determined, including Holter 
ECG monitoring (HMECG)  using the «CardioSens+» system 
(HAI-MEDICA, Ukraine). For a more objective evaluation of 
the HRV features, monitoring was conducted under condition 
of free movement of the patients. All HRV parameters are 
calculated on ‘normal-to-normal’ (NN) inter-beat intervals (or 
NN intervals) caused by normal heart contractions paced by 
sinus node depolarization.
In  the  interim,  analysis  included  the  indicators 
recommended by the standards of measurement, physiological 
interpretation and clinical use of heart rate variability, such as: 
standard deviation of all R-R intervals over the entire 24-hour 
period (SDNN), standard deviation of the mean RR-intervals 
counted  for  each  successive  five-minute  time  intervals  for 
the entire ECG recording and serves to assess the variability 
of low-frequency component (SDANN), and square root of 
the  mean  squared  differences  of  successive  NN  intervals, 
characterizing the high-frequency components of variability 
(RMSSD).
Interpretation  of  HRV  was  performed  according  to 
the recommendations of the working group of the European 
Society  of  Cardiology  and  the  North American  Society  of 
Pacing  and  Electrophysiology  (1996).The  reduction  of  the 
total reduction of HRV was taken as SDNN≤100ms, and the 
marked reduction in HRV - SDNN≤50ms. 
Echocardiography was performed using the “Sanoline 
Versa  Pro»  (Siemens,  Germany)  according  to  the  standard 
procedure in the M-and the B-mode using the recommendations 
of  the  American  society  of  echocardiography  (2004).   
Measurements were taken in three consecutive cardiac cycles 
and the average data were obtained. 
End-diastolic  (EDV)  and  end-systolic  (ESV)  left 
ventricular  volumes  were  determined  by  the  “area-length” 
proposed by N. Dodge et al. (1996) using the formula:
 VA/L=0.85×S²/L, 
where  S  -  planimetric  area  measured  LV,  L  -  longitudinal 
dimension of the left ventricle, respectively, in systole and 
diastole, resulting in B-mode of the four-chamber position.
Estimated total LV contractility was held in his ejection 
fraction: EF=(EDV-ESV)/EDV)×100%. 
LV myocardial mass (LVM) is defined by R. Devereux 
et al.[4,5]: 
LVM=1.04×[(EDD+IVSD+PWLVD)³-EDDLV³]-13.6 g, 
where EDD, IVSD, and PWLVD - respectively the transverse 
dimension  of  the  left  ventricle,  interventricular  septum 
thickness  and  left  ventricular  posterior  wall  thickness  in 
diastole obtained from the M-mode access parasternal long 
axis.
For EDV, ESV and LVM also calculated their indexed (to 
the body surface area) values     iEDO=EDV/ BSA, iESV=ESV/
BSA, LVMI=LVM/BSA. 
To calculate the area of the body we used the formula: 
BSA=0.007184×weight×0.423×Height×0.725.
The  endpoints  were  considered  as  indicators  of  the 
development of fatal or nonfatal reinfarction (FRIM, NFRIM). 
When there were lethal outcomes, information regarding the 
circumstances of death was obtained from the medical records.
Results were statistically processed using the software 
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Microsoft Excel 2007. The mean (M) and standard deviation 
(SD) were calculated. Student’s unpaired and paired t-tests 
were  used  to  compare  two  groups  for  data  with  normal 
distribution. Group comparisons with respect to categorical 
variables  are  performed  using  chi-square  tests. A  value  of 
P<0.05 was considered statistically significant.
Results and Discussion
The  purpose  of  this  study  was  to  evaluate  the  HRV 
features  of  and  the  symptoms  of  early  PIR  for  the  early 
identification of the possible predictors of acute myocardial 
ischemia, including those leading to fatal outcomes within six 
months after suffering a primary Q-MI. 
All the patients were divided into two groups:  Group I 
(n=19) consisted of patients who, within six months after the 
initial Q-wave MI, developed FRIM or NFRPIM; Group II 
(n=86) included those patients with a favorable course of the 
disease. 
 As evident from Table 1, the patients in both groups 
belonged to a somewhat similar age category (53.7±6.8 vs 
51.9±8.9; p=0.38). By localization of MI, occurrence of AH, 
as well as the incidence of LV aneurysm, both groups were 
comparable  (p<0.05).  However,  Group  I  patients  in  acute 
Q-MI showed significantly more preserved signs of residual 
myocardial  ischemia,  which  was  manifested  as  early  post-
infarction angina (EPIA) (57.9% vs 33.7%; χ 2 =3.86, p<0.05).
On analysis of the results of the HMECG 47% of the 
cases Group I of patients were noted to have the PDVA. In 
Group II, the frequency of occurrence of the PDVA was 29%, 
although the differences between the groups did not reveal a 
reliable character (χ 2 =2.38; p=0.12).
Traditionally, the HRV is used for risk stratification post 
MI and is assessed by a 24-hour ECG recording. Therefore, to 
be able to reliably predict HRV, measurements should be taken 
not prior to one week after the myocardial infarction, because 
in the early days prognostic assessment is not possible due to 
the alternating changes in the autonomic activity. Following 
this principle, our study was performed in the 10-14 day period 
post MI after relative stabilization of the patient. According to 
the recommendations of the working group of the European 
Society  of  Cardiology  and  the  North American  Society  of 
Pacing and Electrophysiology (1996), one clear indicator of a 
moderate decline is the drop in the HRV SDNN <100 ms, and 
a reliable sign of significant decrease is the SDNN<50 ms. On 
analyzing the overall HRV, the average values     of SDNN in 
patients in Group I were noted to be significantly lower than 
that in the Group II patients (74.84±34.28 vs 104.48±30.1; 
p=0.0002) (Table 2). The same ratio was observed in both 
groups and also the indicator of SDANN (65.29±32.96 vs 92.9 
±27.43; p=0.0004), whereas the mean     RMSSD values of the 
patients of both groups were not significantly different (18.68 
±9.33 vs 24.26±14.62; p=0.12). The percentage of patients 
with reduced HRV in Group I (84.2%) was 1.8 times higher 
than that in Group II (45.3%) (χ 2 =9.42; p=0.002), including 
those patients with a marked reduction in HRV which were 
25% and 5.1% in Groups I and II, respectively (χ  2 =4.61; 
p=0.03). These results once again confirm the position that 
the reduction in the HRV is a significant predictor of overall 
mortality and serious arrhythmic events in patients post MI [6-8].
As mentioned above, the “new balance” occurs after the 
MI based on subsequent dilatation and hypertrophy of the left 
ventricle, which support adequate myocardial function.
Several  distinct  stages  in  the  LV  changes  have  been 
identified in acute MI:
1. In the first hours a necrotic “dead” zone is formed;
2. Within a period of several hours to several days, an 
expansion zone is observed with the LV wall thinning, akinesia 
and paradoxical motions (in the formation of acute aneurysm) 
in the damaged zone;
3.  From  several  days  to  several  months  onwards, 
LV remodeling is seen to occur. On dilating, the LV cavity 
becomes spherical in shape instead of remaining ellipsoid; this 
is accompanied by myocardial hypertrophy, violated systolic 
and diastolic function and reduced contractility.
There are two forms of LV dilatation post MI - early 
and late. Early dilation of the LV occurs in the first 72 hours 
of AMI, where its size is directly dependent upon the size of 
the infarction and the extent of the coronary artery occlusion 
infarct.  Between  the  necrotic  fibers,  the  myocytes  develop 
connective tissue, which improves the elasticity and prevents 
its walls from stretching. Late dilatation occurs over a long 
period after the infarction, wherein stretching occurs in the 
infarct zone of the myocardium.
Table 1. 
Clinical characteristics of patients
Parameters Group I
(n = 19)
Group II
(n=86) χ 2 p All subjects
(n=105)
Age (yr) 53.7 ± 6.8 51.9 ± 8.9   0.38 52.3 ± 8.6
MI localization 
anterior
posterior
 
13 (68.4%)
6 (31.6%)
 
50 (58.1%)
36 (41.9%)
 
0.69
 
0.40
 
63 (60%)
42 (40%)
AH  18 (94.7%) 70 (81.4%) 2.04 0.15 78 (74.3%)
Aneurysm 7 (36.8%) 23 (26.7%) 0.78 0.37 30 (28.6%)
EPIA 11 (57.9%) 29 (33.7%) 3.86 0.049 40 (38%)
PDVA 9 (47%) 25 (29%) 2.38 0.12 34 (32.4%)
FC HF (Killip)
1-2
3-4
 
14 (73.7%)
5 (26.3%)
 
80 (93.1%)
6 (6.9%)
 
6.21
 
0.012
 
94 (89.5%)
11 (10.5%)
Thrombolysis 2 (10.5%) 10 (11.6%) 0.02 0.89 12 (11.4%)
Table 2. 
HRV in the comparison groups
Parameters Group I
(n=19)
Group II
(n=86)
p
mRR, ms 875.52±162.79 893.8±118.03 0.57
SDNN, ms 74.84±34.28 104.48±30.1 0.0002
SDANN, ms 65.29±32.96 92.9±27.43 0.0004
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On analyzing the nature of the early PIR, it was found 
that  patients  in  Group  I  compared  with  Group  II  patients 
had  significantly  higher  values      for  LVM  (290.9±52.02  vs 
253.4±6.3;  p=0.03),  EDV  (175.72±52.9  vs  148.55±50.78; 
p=0.04), ESV(103.34±3.2 vs 75.78±42.9; p=0.01), as well as 
their indexed values for     LVMI (151.38±23.17 vs 129.2±32.05; 
p=0.006), iEDV (91.86±29.25 vs 75.56±23.01; p=0.01), and 
iESV  (54.21±23.7  vs  38.5±20.14;  p=0.004).  The  average 
values     of EF in Group I were significantly lower than those in 
Group II (42.2±9.8 vs 50.68±11.45; p=0.004) (Table 3).
As  seen  from  Table  3,  patients  with  recurrent  MI 
differed from patients with a favorable course of the disease 
revealing significantly greater LV volume indicator, degree of 
hypertrophy, as well as lesser myocardial contractility, which 
influenced the clinical course of the disease in the acute phase 
of the disease. In Group I, the patients show significantly more 
similarity in the FC 3-4 of the HF (5 (26.3%) vs 6 (6.9%); χ 2 
=6.2, p=0.012)) (Table 1).  
Conclusions
In  patients  with  recurrent  MI,  which  had  developed 
within six months from the time of the initial Q-infarction in 
the acute phase of the disease, significantly more preserved 
signs of residual ischemia were revealed.
The average EF, SDNN and SDANN values     in these 
patients  were  significantly  lower  than  in  patients  having  a 
favorable course of the disease.
Patients  with  recurrent  MI  differed  significantly  by 
showing  higher  values      of  the  left  ventricular  mass,  left 
ventricular  volume  indices,  as  well  as  the  indexed  values     
determined during the 10-14 day period of the primary IM.
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Table 3. 
Echo parameters in the comparison groups
Parameters Group I
(n=19)
Group II
(n=86)
p
LVM, g  290.9±52.02 253.4±68.3 0.03
LVMI, g/m²  151.38±23.17 129.2±32.05 0.006
EDV, ml 175.72±52.9 148.55±50.7 0.04
ESV, ml 103.34±43.2 75.78±42.9 0.01
iEDV, ml/m² 91.86±29.24 75.56±23.0 0.01
iESV, ml/m² 54.22±23.71 38.46±20.14 0.004
EF, % 42.2±9.8 50.68±11.45 0.004